Journal of Chemistry

Journal of Chemistry / 2013 / Article

Research Article | Open Access

Volume 2013 |Article ID 183130 | https://doi.org/10.1155/2013/183130

Mohamed S. Mostafa, Nasser M. Abd El-Salam, Othman Y. Alothman, "Synthesis and Microbial Activity of Novel 3-Methyl-2-pyrazolin-5-one Derivatives", Journal of Chemistry, vol. 2013, Article ID 183130, 7 pages, 2013. https://doi.org/10.1155/2013/183130

Synthesis and Microbial Activity of Novel 3-Methyl-2-pyrazolin-5-one Derivatives

Academic Editor: Philippe Jeandet
Received18 Dec 2012
Revised14 Mar 2013
Accepted27 Mar 2013
Published16 Apr 2013

Abstract

2-Oxo-2H-chromene-3-carbohydrazide derivatives 2a,b react with 2-{[4-(substituted thiazol-2-yl)iminoethyl)-phenyl]hydrazono}-3-oxo-butyric acid ethyl esters 4ac to give 3-methyl-1-[(2-oxo-2H-chromen-3-yl) carbonyl]-4-{[4-(substituted thiazol-2-yl)iminoethyl)-phenyl]hydrazono}]-2-pyrazolin-5-one derivatives 5af. A considerable increase in the reaction rate had been observed with better yield using microwave irradiation for the synthesis of compounds 2a, b, 3ac, and 5af. The synthesized products were tested against B. subtilis, S. aureus, and E. coli as well as C. albicans compared with tetracycline and nystatin as reference drugs.

1. Introduction

Pyrazolones are an increasingly popular functionality with wide-range applications. They are used as antibacterial [1], antifungal [2], anti-inflammatory [3], cytotoxic [4], analgesic [5], antiviral [6], and SARS-corona virus 3C-like protease inhibitors [7] agents. Furthermore, 4-(1,3-benzothiazol-2-yl)hydraziny lidene-2,4-dihydro-3H-pyrazol-3-one derivatives have shown good antioxidant activity [8]. On the other hand, the iminothiazoline derivatives have been reported to exhibit antibacterial and antifungal activities [9, 10]. Coumarin derivatives possess various biological activities namely antibacterial [11, 12], antifungal [13], antitumor [14], anticoagulant [15], and anti-inflammatory agents [16]. These compounds are used as additives in food and cosmetics [17], dispersed fluorescent brightening agents, and as dyes for tuning lasers [18]. Microwave irradiation is well known to promote the synthesis of a variety of organic compounds [1921] where chemical reactions are accelerated because of selective absorption of microwave by polar molecules. In view of these observations we report herein the synthesis of some pyrazolone derivatives, using conventional and microwave irradiated methods, with the hope to get better antimicrobial agents.

2. Experimental

Melting points were estimated using a Stuart apparatus in open capillaries. Purity of compounds was checked by TLC. IR spectra were recorded as KBr pellets on a Jasco FTIR 460 plus spectrophotometer. 1H-NMR spectra were recorded using a Bruker AV 500 MHz spectrometer using DMSO-d6 as solvent and TMS as an internal standard. The mass spectral data were obtained with a Micro Spectrometer model 7070 at 70 eV and a 90°C inlet temperature. Elemental analyses were performed on a Perkin-Elmer 240 microanalyser in the Faculty of Science, Cairo University. Microwave irradiations (MWIs) were carried out in a SANYO EM-700T domestic oven (700 W).

3. Synthesis of 2-Oxo-2H-Chromene-3-carbohydrazides (2a,b)

3.1. Method I

A mixture of ethyl-2-oxo-2H-chromene-3-carboxylates (1a,b) (0.01 mole) and hydrazine hydrate 98% (0.5 mole) was refluxed for 2 h. The reaction mixture was poured into water and then the separated solid was filtered off and recrystallized from ethanol to give 2a, b (Tables 1 and 2).


CompM.P. (°C)Solvent of crystn.Yield (%)Formula (M.W.)Analysis calcd./found
CHNS

2a144–146Ethanol75
C10H8N2O358.823.9513.71
(204.185)58.813.9713.75
2b210–212Ethanol60
C10H7BrN2O342.432.499.89
(283.081)42.482.469.91
3a [23]201–204Ethanol62C11H11N3S60.805.1019.3314.75
(217.29)60.815.1319.3814.71
3b230–232Ethanol58
C12H13N3S62.855.7118.3213.98
(229.301)62.865.7318.3714.01
3c271–273EtOH-H2O50
C15H13N3S67.384.9015.7111.99
(267.35)67.404.9115.6911.96
4a [23]165–167Ethanol66C17H18N4O3S56.965.0615.638.94
(358.416)56.985.0415.678.98
4b186–188Ethanol62
C18H20N4O3S58.045.4115.048.60
(372.443)58.095.4015.078.66
4c140–142Ethanol60
C21H20N4O3S61.744.9313.717.84
(408.476)61.784.9613.697.88
5a208–210Ethanol60
C25H18N6O4S60.233.6316.856.43
(498.517)60.203.6616.806.47
5b232–234Ethanol54
C26H20N6O4S60.923.9316.396.25
(512.544)60.943.9816.426.30
5c222–224DMF57
C29H20N6O4S63.493.6715.325.84
(548.577)63.513.6215.385.88
5d280–282DMF50
C25H17BrN6O4S52.002.9614.555.55
(577.413)52.083.9914.515.59
5e250–252DMF48
C26H19BrN6O4S52.803.2314.205.42
(591.44)52.783.2014.285.45
5f264–267Pet-ether37C29H19BrN6O4S55.513.0513.395.10
(627.473)55.503.0313.415.12


Compd.ConventionalMicrowave
% yield /hrs % yield /min

2a752943
2b602983
3a644823
3b584863.5
3c504892
5a60
8933
5b54
8883
5c57
8823
5d50
9913
5e48
8833
5f378814

3.2. Method II

Hydrazine hydrate (0.01 mole), 1a,b (0.01 mole), and absolute ethanol (2 mL) were irradiated in an Erlenmeyer flask under MWI for 3 min. The reaction mixture was cooled, and the separated solid was filtered off and washed with water to yield 2a,b (Table 3).


Comp.IR cm−1 1H-NMR δ ppmMS

2a3304–3245 (NH2), 3078 (NH), 1730 (lactone C=O) and 1682 cm−1 (amidic CO).7.01–7.48 (m, 3H, ArH), 9.36 (s, 1H, CH-4), 11.14 (s, 1H, NH) and 12.01 (s, 2H, NH2).M+: 204 (100%)

2b3311–3239 (NH2), 3046 (NH), 1721 (lactone C=O) and 1680 cm−1 (amidic CO) 7.12–7.54 (m, 3H, ArH), 9.41 (s, 1H, CH-4), 11.21 (s, 1H, NH) and 12.11 (s, 2H, NH2).M+1: 284 (32.67%), M+: 283 (61.06%)

3b3400–3312 (NH2), 1640 (C=N)2.01 (s, 3H, CH3), 2.72 (s, 3H, CH3), 6.88 (s, 2H, NH2, D2O-exchangeable, 7.22–7.82 (m, 5H, ArH).M+: 229 (100%), 97 (55.98%).

3c3400–3312 (NH2), 1640 (C=N)2.78 (s, 3H, CH3), 6.10 (s, 2H, NH2, D2O-exchangeable, 7.35–7.68 (m, 8H, ArH).M+: 267 (46.11%), 133 (100%).

4b1760 (C=O), 1630 (C=N), 1560 (N=N).
0.91 (s, 3H, CH3), 1.21 (t, 3H, OCH2CH3), 2.60 (s, 3H, CH3), 2.88 (s, 3H, CH3), 3.0 (s, 1H, CH), 4.20–4.22 (q, 2H, OCH2CH3), 6.70–7.60 (m, 5H, ArH).M+: 372 (88.34%), 328 (22.56%), 254 (43.87%), 156 (52%).

4c1755 (C=O), 1622 (C=N), 1560 (N=N).1.27 (t, 3H, OCH2CH3), 2.57 (s, 3H, CH3), 2.80 (s, 3H, CH3), 3.22 (s, 1H, CH), 4.27–4.29 (q, 2H, OCH2CH3), 6.66–7.98 (m, 8H, ArH).M+: 408 (22.11%), 364 (56.54%), 290 (78.23%), 156 (23.11%).

5a3202 (NH), 1710 (lactone CO), 1677 (CO), 1586 (C=N).2.03 (s, 3H, CH3), 2.92 (s, 3H, CH3), 4.58 (s, 1H, CH), 7.31–7.52 (m, 10H, ArH), 9.72 (s, 1H, CH-4), 11.40 (s, 1H, NH, disappeared after D2O exchange)M+: 498 (23.11%), 267 (52.34%), 229 (26.87%), 121 (7.08%), 92 (17.58%), 84 (39.76%).

5b3106 (NH), 1719 (lactone CO), 1680 (CO), 1582 (C=N).1.44 (s, 3H, CH3), 2.03 (s, 3H, CH3), 2.88 (s, 3H, CH3), 4.61 (s, 1H, CH), 7.31–7.52 (m, 9H, ArH), 9.66 (s, 1H, CH-4), 11.07 (s, 1H, NH, disappeared after D2O exchange)M+: 512 (42.26%), 267 (65%), 242 (36.98%), 121 (19.78%), 97 (14.44%), 92 (22.32%)

5c3135 (NH), 1713 (lactone CO), 1654 (CO), 1567 (C=N).2.45 (s, 3H, CH3), 2.99 (s, 3H, CH3), 4.28 (s, 1H, CH), 6.78–8.89 (m, 12H, ArH), 9.21 (s, 1H, CH-4), 11.11 (s, 1H, NH, disappeared after D2O exchange)M+: 548 (100%), 279 (15.47%), 267 (25.96%), 133 (44.11%), 121 (45.34%), 92 (13.67%).

5d3065 (NH), 1722 (lactone CO), 1682 (CO), 1560 (C=N).2.19 (s, 3H, CH3), 2.86 (s, 3H, CH3), 4.65 (s, 1H, CH), 7.11–7.95 (m, 9H, ArH), 9.70 (s, 1H, CH-4), 11.32 (s, 1H, NH, disappeared after D2O exchange)M+1: 578 (22.52%), M+: 577 (78.93%), 344 (32.33%), 229 (21.45%), 84 (76.23%).

5e3116 (NH), 1709 (lactone CO), 1673 (CO), 1551 (C=N).1.31 (s, 1H, CH3), 2.73 (s, 3H, CH3), 2.99 (s, 3H, CH3), 4.95 (s, 1H, CH), 7.11–7.54 (m, 8H, ArH), 9.72 (s, 1H, CH-4), 11.98 (s, 1H, NH, disappeared after D2O exchange)M+1: 520 (98%), M+: 519 (38%), 344 (16.95%), 242 (68.23%), 121 (19%), 97 (23.31%).

5f3109 (NH), 1725 (lactone CO), 1686 (CO), 1509 (C=N).2.19 (s, 3H, CH3), 2.86 (s, 3H, CH3), 4.65 (s, 1H, CH), 6.91–8.12 (m, 11H, ArH), 9.04 (s, 1H, CH-4), 10.56 (s, 1H, NH, disappeared after D2O exchange)M+1: 628 (15.12%), M+: 627 (34%), 344 (71.71%), 279 (51.11%), 133 (55.04%).

4. Synthesis of 1-(4-Aminophenyl)-1-(substituted thiazol-2-yl)iminoethanes 3a–c

4.1. Method I

A mixture of 4-aminoacetophenone (0.01 mole) and the appropriate amine, namely, (2-aminothiazole, 2-amino-5-methylthiazol and 2-aminobenzothiazole) (0.01 mole for each) in DMF (30 mL) was heated under reflux for 4 h. The precipitated solid formed after cooling was collected by filtration. Then, it was washed with water, dried, and crystallized to afford 3ac (Tables 1 and 2).

4.2. Method II

A solution of 4-aminoacetophenone (0.01 mole) in methanol (30 mL) and 2-aminothiazoles (0.01 mole) was put in round-bottomed flask placed in a microwave oven and irradiated for 2.0–3.5 min, and then the solvent was removed by vacuum distillation. The solid product was filtered, dried, and recrystallized from ethanol to give 3ac (Table 3).

5. Synthesis of 2-{[4-(Substituted thiazol-2-yl)iminoethyl)-phenyl]Hydrazono}-3-oxo-Butyric Acid Ethyl Ester 4a–c

A solution of sodium nitrite (0.01 mole) in water (10 mL) was added to an ice-cooled mixture of 3ac (0.01 mole) in concentrated HCl (10 mL) and water (10 mL). The diazotized compound was dropped while cooling with stirring over a cold mixture of ethyl acetoacetate (0.01 mole) and sodium acetate (2 g in 10 mL water) in ethanol (20 mL). The reaction mixture was stirred at room temperature for 8 h. The precipitated solid was collected by filtration. Then it was washed with water, dried, and recrystallized to afford 4ac (Tables 1 and 2).

6. Synthesis of 3-Methyl-1-[(2-oxo-2H-chromen-3-yl) carbonyl]-4-{[4-(substituted thiazol-2-yl)iminoethyl)-phenyl]hydrazono}]-2-pyrazolin-5-one Derivatives (5a–f)

6.1. Method I

A mixture of 4a–c (0.002 mole for each) and (2a,b) (0.002 mole for each) in acetic acid (15 mL) was refluxed for 8 h. The reaction mixture was then allowed to stand overnight. After conclusion of the reaction (TLC), the reaction mixture was poured onto crushed ice to give sticky product which was extracted from ether for three times. The organic layer was washed with water. Then, it was dried with MgSO4 and filtered. After that, the solvent was removed under vacuum to give 5a–f (Tables 1 and 2).

6.2. Method II

A mixture of 4a–c (0.01 mole for each), 2a,b (0.01 mole for each), and glacial acetic acid (2 mL) in an Erlenmeyer flask was exposed to pulsed microwave irradiation using microwave oven for 3 min. The reaction mixture was poured onto crushed ice; the separated solid was filtered, then washed with water, and dried to give the pyrazolin-5-ones 5af (Table 3).

7. Results and Discussion

Treatment of ethyl-2-oxo-2H-chromene-3-carboxylates (1a,b) [22] with hydrazine hydrate under heating reflux afforded 2-oxo-2H-chromene-3-carbohydrazide derivatives 2a,b. Again, compounds 2a,b were obtained in a 94–98% yield by irradiation of (1a,b) with hydrazine hydrate in ethanol under MWI for 3 min (Figure 1).

The IR (KBr) of compounds 2a,b displayed absorption bands at 3321(NH2), 3078(NH), 1730(lactone C=O), and 1682 cm−1 for amidic CO. The structure of 2b was also confirmed by its mass spectrum that shows molecular ion peaks (M+) at m/z 283(61.06%, 79Br) and m/z 284(32.67%, 81Br).

It has been found that the 4-aminoacetophenone reacted with 2-amino-5-methylthiazole or 2-aminobenzothiazole in DMF to give the imino derivatives (3b,c), similar to compound (3a) [23]. It was found that the higher yields of compounds 3ac were obtained at 500 watt for 2-3 min of microwave irradiation (Figure 2).

IR spectrum (KBr) of 3b, as an example, showed bands at 3400-3388 (NH2), and 1640 cm−1 for C=N. The 1H-NMR spectrum (DMSO-d6) of 3b showed signals at δ 2.01 (s. 3H, CH3), 2.72 (s. 3H, CH3), 6.88 (s, 2H, NH2, D2O-exchangeable), and 7.22–7.82 ppm (m, 5H, ArH). Diazotization of 3ac followed by coupling with ethyl acetoacetate in presence of sodium acetate gave 2-{[4-(substituted thiazol-2-yl)iminoethyl)-phenyl]hydrazono}-3-oxo-butyric acid ethyl esters 4ac (Figure 3).

IR spectra of 4ac revealed no absorption band in amino group region; furthermore, it displayed absorption bands at 1760 and 1560 cm−1 for ester group and (N=N), respectively. The 1H-NMR spectrum (DMSO-d6) of compound 4c, as an example, exhibited signals at δ 1.27 (t, 3H, OCH2CH3), 2.57 (s, 3H, CH3), 2.80 (s, 3H, CH3), 3.22 (s, 1H, CH), 4.27–4.29 (q, 2H, OCH2CH3) and 6.66–7.98 ppm (m, 8H, ArH).

Refluxing compounds 2a,b and 4ac in acetic acid for 8 hrs lead to 3-methyl-1-[(2-oxo-2H-chromen-3-yl) carbonyl]-4-{[4-(substituted thiazol-2-yl)iminoethyl)-phenyl]hydrazono}]-2-pyrazolin-5-one derivatives 5af. These pyrazolin-5-one derivatives were obtained in good yield through the irradiation of a mixture of 2a,b and 4a–c using microwave oven for 3-4 min (Figure 4).

The 1H-NMR spectrum (DMSO-d6) of compounds 5a, as an example, showed signals at δ 2.03 (s, 3H, CH3), 2.92 (s, 3H, CH3), 4.58 (s, 1H, CH), 7.31–7.52 (m, 10H, ArH), 9.72 (s, 1H, CH-4), and 11.40 ppm (s, 1H, NH, disappeared after D2O exchange). The infrared spectrum of compounds 5af revealed absorption bands characteristic for NH, lactone CO, CO, and C=N. The mass spectra of compounds containing bromine atoms (5d,5e, and 5f) showed fragments corresponding to the typical bromine isotope (79Br and 81Br) patterns. Thus, the mass spectrum of 5d shows its M+1 and M+ peaks at m/z 578 (22.52%) and 577 (78.93%), respectively (Table 3).

8. Antimicrobial Activity

The antimicrobial activity of new compounds was investigated against a variety of microorganisms, including the gram-positive bacteria Bacillus subtilis and Staphylococcus aureus and the gram-negative bacteria Escherichia coli as well as the unicellular fungi Candida albicans. The agar plate disc-diffusion method [24] was used to assess the activity of the compounds. Sterilized filter paper discs (5 mm in diameter) were wetted with 10 μL each of a solution of the tested compound (10 mg/mL of the compound in DMF). The discs were then allowed to dry and were placed on the surface of agar plates seeded with the test organism. Nutrient agar was used for bacterial plating and sabourauds dextrose agar for fungi. Each plate contained 15 mL of the agar medium, previously seeded with 0.2 mL of an 18 h-old broth culture of each organism. The inoculated plates were incubated at 37°C for 48 h with the test discs in place, and the inhibition zones were measured in mm. Controls including the use of the solvent DMF without test compounds that showed no antimicrobial activity for this solvent. The antibacterial reference tetracycline discs and the antifungal reference nystatin discs were tested concurrently as standards.

Concerning the data of antimicrobial activity in Table 4, some of the synthesized compounds showed antibacterial activity comparable to that of tetracycline (the reference drug used). Concerning the activity against gram-positive bacteria (Bacillus subtilis), 3-methyl-1-[(2-oxo-2H-chromen-3-yl)carbonyl]-4-[(4-thiazol-2-yl)iminoethyl)phenyl) hydrazon]-2-pyrazolin-5-one derivative (5a) showed excellent activity, and compounds 5b and 5d exhibited good activity, whereas compounds 4c,5e, and 5f showed moderate activity. All synthesized compounds exhibited moderate activity against Staphylococcus aureus. Compounds 5a and 5f showed excellent activity against gram-negative bacteria Escherichia coli. On the other hand, the unicellular fungi Candida albicans showed high responses to 5d.


Compd. no.Inhibition zones (mm)
Gram +ve bacteriaGram −ve bacteriaFungi
B. subtilis S. aureus E. coli C. albicans

2a18141219
2b13101120
3b16141013
3c14121511
4b17181822
4c22171620
5a29102119
5b23101118
5c19152010
5d23101925
5e22141315
5f20182213
Tetracycline282620
Nystatin24

9. Conclusion

This paper describes the synthesis, spectral characterization, and screening of antimicrobial activity of some 3-methylpyrazolin-5-one derivatives bearing side chains, imino-thiazole-phenylhydrazone derivatives, and coumarin moiety. Microwave-assisted synthesis was also used to improve the yield and reaction time. The synthesized compounds showed a wide range of potentially promising antimicrobial activities.

Acknowledgment

The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding the work through the research group project no. RGP-VPP-133.

References

  1. P. T. Pavlov, A. F. Goleneva, A. E. Lesnov, and T. S. Prokhorova, “Biological activity of some pyrazolone derivatives,” Pharmaceutical Chemistry Journal, vol. 32, no. 7, pp. 370–372, 1998. View at: Google Scholar
  2. D. Singh and D. Singh, “Synthesis and antifungal activity of some 4-arylmethylene derivatives of substituted pyrazolones,” Journal of the Indian Chemical Society, vol. 68, no. 3, pp. 165–167, 1991. View at: Google Scholar
  3. G. Mariappan, B. P. Saha, L. Sutharson, and A. Haldar, “Synthesis and bioactivity evaluation of pyrazolone derivatives,” Indian Journal of Chemistry B, vol. 49, no. 12, pp. 1671–1674, 2010. View at: Google Scholar
  4. H. P. Devnath and R. Islam, “Synthesis of some pyrazolone derivatives from ciprofloxacin and study of their cytotoxicity,” Bangladesh Journal of Pharmacology, vol. 5, no. 1, pp. 30–34, 2010. View at: Publisher Site | Google Scholar
  5. M. Amir and S. Kumar, “Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of 3,5-dimethyl pyrazoles, 3-methyl pyrazol-5-ones and 3,5-disubstituted pyrazolines,” Indian Journal of Chemistry B, vol. 44, no. 12, pp. 2532–2537, 2005. View at: Google Scholar
  6. A. N. Evstropov, V. E. Yavorovskaya, E. S. Vorob'ev et al., “Synthesis and antiviral activity of antipyrine derivatives,” Pharmaceutical Chemistry Journal, vol. 26, no. 5, pp. 426–430, 1992. View at: Publisher Site | Google Scholar
  7. R. Ramajayam, K. P. Tan, H. G. Liu, and P. H. Liang, “Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors,” Bioorganic and Medicinal Chemistry, vol. 18, no. 22, pp. 7849–7854, 2010. View at: Publisher Site | Google Scholar
  8. K. Siva and A. Rajasekharan, “Synthesis and Characterisation, in vitro antioxidants activity of N-mannich base of pyrazolone derivatives,” International Journal of Research of Pharmacy and Chemistry, vol. 2, no. 2, pp. 327–337, 2012. View at: Google Scholar
  9. A. Gürsoy and N. Karali, “Synthesis, characterization and primary antituberculosis activity evaluation of 4-(3-Coumarinyl)-3-benzyl-4-thiazolin-2-one benzylidenehydrazones,” Turkish Journal of Chemistry, vol. 27, no. 5, pp. 545–551, 2003. View at: Google Scholar
  10. S. Hiremath, K. Swamy, and B. Mruthyunjayaswamy, “Synthesis and antimicrobial activity of 4-amino-3-(2’-phenyindol-3’-yl)-2-imino-4-thiozoline-5-carbonitrilies and their derivatives,” Journal of the Indian Chemical Society, vol. 69, p. 87, 1992. View at: Google Scholar
  11. O. A. Abd Allah, “Synthesis and biological studies of some benzopyrano[2,3-c]pyrazole derivatives,” Farmaco, vol. 55, no. 9-10, pp. 641–649, 2000. View at: Publisher Site | Google Scholar
  12. A. M. El-Agrody, M. S. Abd El-Latif, N. A. El-Hady, A. H. Fakery, and A. H. Bedair, “Heteroaromatization with 4-Hydroxycoumarin Part II: synthesis of some new pyrano[2,3-d]pyrimidines, [1,2,4]triazolo[1,5-c]pyrimidines and pyrimido[1,6-b]-[1,2,4]triazine derivatives,” Molecules, vol. 6, no. 6, pp. 519–527, 2001. View at: Google Scholar
  13. M. A. Al-Haiza, M. S. Mostafa, and M. Y. El-Kady, “Synthesis and biological evaluation of some new coumarin derivatives,” Molecules, vol. 8, no. 2, pp. 275–286, 2003. View at: Google Scholar
  14. F. Belluti, G. Fontana, L. D. Bo, N. Carenini, C. Giommarelli, and F. Zunino, “Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: identification of novel proapoptotic agents,” Bioorganic and Medicinal Chemistry, vol. 18, no. 10, pp. 3543–3550, 2010. View at: Publisher Site | Google Scholar
  15. H. El-Diwani and H. El-Sahrawi, “Synthesis and anticoagulant, antipyretic and analgesic activities of some 4H-1benzopyran-4-one derivatives,” Indian Journal of Chemistry B, vol. 34, pp. 27–31, 1995. View at: Google Scholar
  16. K. N. Venugopala and B. S. Jayashree, “Synthesis of carboxamides of 2-amino-4-(6-bromo-3-coumarinyl) thiazole as analgesic and antiinflammatory agents,” Indian Journal of Heterocyclic Chemistry, vol. 12, no. 4, pp. 307–310, 2003. View at: Google Scholar
  17. R. O'Kennedy and R. Thornes, Coumarins: Biology, Applications and Mode of Action, John Wiley & Sons, Chichester, UK, 1997.
  18. M. Zahradnik, The Production and Application of Fluorescent Brightening Agent, John Wiley & Sons, Chichester, UK, 1992.
  19. P. Gothwal, G. Malhotra, and Y. K. Srivastava, “Microwave Assisted Synthesis and antimicrobial activities of some 3-[4'-(4“-nitrophenoxy)-phenyl] -5-(substituted aryl)-2-pyrazoline-1- thiocarboamides,” International Journal of Green and Herbal Chemistry, vol. 1, no. 1, pp. 39–45, 2012. View at: Google Scholar
  20. B. Parashar, S. Bhardwaj, S. Sharma, G. Gupta, V. Sharma, and P. Punjabi, “Comparative conventional and microwave assisted synthesis of some pyrazoline derivatives and their antimicrobial activity,” Journal of Chemical and Pharmaceutical Research, vol. 2, no. 3, pp. 33–42, 2010. View at: Google Scholar
  21. M. Srinivas, A. Tejasri, N. Anjaneyulu, and K. Satyanarayana, “Microwave assisted synthesis and antimicrobial activity of some novel quinoxaline compounds,” International Journal of Pharma Sciences, vol. 3, no. 1, pp. 142–146, 2013. View at: Google Scholar
  22. K. Suresh, M. Veeresh, A. Prashant et al., “Synthesis and pharmacological evaluation of a novel series of 5-(substituted)aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents,” European Journal of Medicinal Chemistry, vol. 30, pp. 1–7, 2008. View at: Google Scholar
  23. F. E. Goda, A. R. Maarouf, and E. R. EL-Bendary, “Synthesis and antimicrobial evaluation of new isoxazole and pyrazole derivatives,” Saudi Pharmaceutical Journal, vol. 11, no. 3, pp. 111–117, 2003. View at: Google Scholar
  24. C. H. Collins and P. M. Lyne, Microbiological Methods, Butterworths, London, UK, 4th edition, 1976.

Copyright © 2013 Mohamed S. Mostafa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views3221
Downloads1614
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.